That’s $5.3 billion less than the deferred tax liability that Pfizer has booked. Joan Campion, a spokeswoman for Pfizer, didn’t respond to requests for comment.
“Companies with big DTLs really, really want a repatriation,” Texas A&M’s Robinson said. “It’s like getting something for nothing.”
This article was provided by Bloomberg News.